Home > PB Ratio > GLAND PHARMA

GLAND PHARMA
PB (Price/Book ) Ratio

The Current P/B Ratio of GLAND PHARMA is 3.35.

Share Price ₹1,775.4Dec 11,2024
Market Cap ₹29,257.8 Cr
Book Value₹8,722.5 CrMar2024 - Consolidated Results
Price/Book 3.35xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Top Undervalued Mid Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of GLAND PHARMA

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of GLAND PHARMA is calculated as :

Current Market Cap [ ₹29,257.8 Cr] as on Dec 11,2024

(/) Book Value [ ₹8,722.5 Cr] based on Mar2024 - Consolidated Results

(=) P/B Ratio [ 3.35x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for GLAND PHARMA , the investors are currently willing to pay '3.35 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of GLAND PHARMA !

The chart below summarizes the trend in P/B Ratio of GLAND PHARMA over the last five years.

Historical PB (Price/Book ) ratio chart of GLAND PHARMA


PB Ratio Performance Analysis for GLAND PHARMA

- GLAND PHARMA 's latest p/b ratio is 3.35x.

- GLAND PHARMA 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 4.11x.

- GLAND PHARMA 's operated at median p/b ratio of 3.48x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GLAND PHARMA 's p/b ratio peaked in Mar2022 at 7.52x.

- GLAND PHARMA 's p/b ratio hit its five-year low in Mar2020 of 0x.


How does GLAND PHARMA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
GLAND PHARMA 8,722.463.3529,257.8
SUN PHARMACEUTICAL INDUSTRIES LTD63,666.806.84435,407.0
CIPLA LTD26,619.904.41117,443.0
DR REDDYS LABORATORIES LTD28,123.503.67103,338.0
ZYDUS LIFESCIENCES LTD19,829.505.0099,244.9
DIVIS LABORATORIES LTD13,571.0011.60157,489.0
MANKIND PHARMA LTD9,339.8411.25105,098.0
TORRENT PHARMACEUTICALS LTD6,856.1516.66114,202.0
LUPIN LTD14,175.806.9298,055.1
AUROBINDO PHARMA LTD29,842.802.3971,188.9
ABBOTT INDIA LTD3,658.7316.7661,336.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs GLAND PHARMA 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.39x
Max industry PB 16.76x
Median industry PB 6.84x
Average industry PB 8.08x



You may also like the below Video Courses